Works matching IS 03000664 AND DT 2022 AND VI 96 AND IP 5
Results: 11
Mutation based approaches to the treatment of anaplastic thyroid cancer.
- Published in:
- Clinical Endocrinology, 2022, v. 96, n. 5, p. 734, doi. 10.1111/cen.14679
- By:
- Publication type:
- Article
High prevalence of hypertension and target organ damage in patients with 11β‐hydroxylase deficiency.
- Published in:
- Clinical Endocrinology, 2022, v. 96, n. 5, p. 657, doi. 10.1111/cen.14677
- By:
- Publication type:
- Article
The impact of adherence and therapy regimens on quality of life in patients with congenital adrenal hyperplasia.
- Published in:
- Clinical Endocrinology, 2022, v. 96, n. 5, p. 666, doi. 10.1111/cen.14676
- By:
- Publication type:
- Article
Age increased the cancer‐specific mortality risk of thyroid cancer with lung metastasis.
- Published in:
- Clinical Endocrinology, 2022, v. 96, n. 5, p. 719, doi. 10.1111/cen.14675
- By:
- Publication type:
- Article
Elevated serum uric acid is a facilitating mechanism for insulin resistance mediated accumulation of visceral adipose tissue.
- Published in:
- Clinical Endocrinology, 2022, v. 96, n. 5, p. 707, doi. 10.1111/cen.14673
- By:
- Publication type:
- Article
The dietary inflammatory index is directly associated with polycystic ovary syndrome: A case‐control study.
- Published in:
- Clinical Endocrinology, 2022, v. 96, n. 5, p. 698, doi. 10.1111/cen.14672
- By:
- Publication type:
- Article
Mass spectrometry‐based cortisol profiling during adrenal venous sampling reveals misdiagnosis for subtyping primary aldosteronism.
- Published in:
- Clinical Endocrinology, 2022, v. 96, n. 5, p. 680, doi. 10.1111/cen.14666
- By:
- Publication type:
- Article
Predictive factors for thyroid complications after radiation therapy—data from a cohort of cancer patients closely followed since they were irradiated.
- Published in:
- Clinical Endocrinology, 2022, v. 96, n. 5, p. 728, doi. 10.1111/cen.14665
- By:
- Publication type:
- Article
Hypoglycemia associated with direct‐acting anti‐hepatitis C virus drugs: An epidemiologic surveillance study of the FDA adverse event reporting system (FAERS).
- Published in:
- Clinical Endocrinology, 2022, v. 96, n. 5, p. 690, doi. 10.1111/cen.14660
- By:
- Publication type:
- Article
Instructions for authors.
- Published in:
- Clinical Endocrinology, 2022, v. 96, n. 5, p. 743, doi. 10.1111/cen.14524
- Publication type:
- Article
Issue Information.
- Published in:
- Clinical Endocrinology, 2022, v. 96, n. 5, p. 655, doi. 10.1111/cen.14523
- Publication type:
- Article